tradingkey.logo
tradingkey.logo
Search

Passage Bio Inc

PASG
Add to Watchlist
4.470USD
-0.020-0.45%
Close 07-31 16:00ETQuotes delayed by 15 min
14.23MMarket Cap
LossP/E TTM

PASG Financials

See Passage Bio Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Passage Bio Inc Earnings Date

Latest Release
May 12, 2026
EPS / Forecast
-2.36/-2.79
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-14.35
33.09%
Analyst Rating
HOLD
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
52.47%-2.36
0.76%-4.08
61.07%-2.44
-1041.76%-59.20
16.44%-4.96
32.63%-4.11
36.72%-6.26
40.57%-5.18
52.78%-5.94
38.44%-6.11
---9.90
---8.72
---12.57
---9.92
---2.01
----
----
----
----
----
Net Profit
50.93%-7.56M
-2.03%-12.98M
59.93%-7.75M
41.31%-9.38M
7.82%-15.40M
24.07%-12.72M
28.66%-19.34M
32.97%-15.99M
51.33%-16.71M
38.10%-16.76M
-1.53%-27.11M
39.67%-23.86M
19.79%-34.34M
47.08%-27.07M
43.09%-26.70M
18.36%-39.54M
-10.10%-42.81M
-31.35%-51.15M
-64.44%-46.91M
-78.25%-48.44M
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
--0.00%
--0.00%
--0.00%
----
----
----
----
----
----
----
Operating profit
35.75%-8.88M
27.54%-10.34M
45.59%-8.65M
39.00%-10.33M
23.42%-13.82M
22.64%-14.27M
31.68%-15.91M
33.28%-16.94M
49.70%-18.05M
34.69%-18.45M
15.42%-23.28M
36.23%-25.39M
16.18%-35.88M
44.79%-28.24M
41.56%-27.53M
17.97%-39.81M
-9.96%-42.81M
-30.99%-51.16M
-64.52%-47.10M
-77.75%-48.53M
Net Profit
50.93%-7.56M
-2.03%-12.98M
59.93%-7.75M
41.31%-9.38M
7.82%-15.40M
24.07%-12.72M
28.66%-19.34M
32.97%-15.99M
51.33%-16.71M
38.10%-16.76M
-1.53%-27.11M
39.67%-23.86M
19.79%-34.34M
47.08%-27.07M
43.09%-26.70M
18.36%-39.54M
-10.10%-42.81M
-31.35%-51.15M
-64.44%-46.91M
-78.25%-48.44M
Current assets
-47.89%34.74M
-39.40%47.76M
-36.10%55.73M
-36.51%60.31M
-38.44%66.67M
-33.18%78.81M
-35.73%87.22M
-38.16%95.00M
-36.90%108.29M
-40.14%117.96M
-39.01%135.71M
-38.69%153.63M
-39.36%171.62M
-39.38%197.04M
-39.28%222.52M
-40.17%250.58M
-37.24%283.00M
2.49%325.07M
4.85%366.47M
13.74%418.84M
Total current liabilities
12.79%20.10M
19.21%23.08M
31.23%22.25M
59.88%19.80M
38.81%17.82M
18.49%19.36M
-14.44%16.95M
-37.67%12.38M
-25.53%12.84M
-10.95%16.34M
-8.36%19.81M
-26.77%19.87M
-37.25%17.24M
-37.79%18.35M
-2.84%21.62M
-13.17%27.13M
41.15%27.48M
39.31%29.50M
16.47%22.25M
121.09%31.25M
Total assets
-57.61%36.46M
-39.19%62.28M
-33.64%74.16M
-36.84%79.20M
-38.80%86.01M
-31.97%102.41M
-33.97%111.75M
-35.26%125.39M
-34.10%140.53M
-38.19%150.54M
-37.32%169.26M
-35.31%193.70M
-36.01%213.24M
-31.41%243.55M
-30.92%270.05M
-31.88%299.42M
-28.37%333.22M
8.25%355.08M
8.99%390.94M
16.25%439.52M
Total liabilities
-37.12%24.71M
5.77%43.53M
10.26%43.04M
17.53%40.94M
10.24%39.30M
4.81%41.15M
-9.18%39.04M
-19.52%34.84M
-16.89%35.65M
-6.92%39.26M
-5.86%42.98M
-15.74%43.28M
-17.38%42.89M
15.83%42.18M
59.00%45.66M
37.88%51.37M
119.34%51.91M
56.35%36.42M
45.11%28.71M
153.42%37.26M
Total equity
-74.84%11.75M
-69.39%18.75M
-57.20%31.12M
-57.75%38.26M
-55.47%46.71M
-44.95%61.26M
-42.42%72.72M
-39.79%90.56M
-38.43%104.88M
-44.74%111.28M
-43.73%126.28M
-39.36%150.41M
-39.44%170.35M
-36.81%201.37M
-38.05%224.40M
-38.34%248.05M
-36.28%281.31M
4.58%318.66M
6.88%362.23M
10.70%402.27M
Net operating income
6.21%-12.99M
23.27%-6.48M
34.83%-4.85M
51.81%-6.33M
26.85%-13.85M
56.73%-8.44M
61.14%-7.45M
23.36%-13.14M
15.67%-18.93M
18.75%-19.52M
18.09%-19.16M
34.29%-17.14M
49.80%-22.45M
21.95%-24.02M
43.02%-23.39M
-7.21%-26.08M
-45.55%-44.71M
-4.59%-30.77M
-134.20%-41.06M
-107.68%-24.33M
Net investment
-99.95%20.00K
-100.00%0.00
-100.00%0.00
-44.18%585.00K
56.95%39.63M
79.97%13.68M
-33.33%14.97M
-92.50%1.05M
19.01%25.25M
326.33%7.60M
571.86%22.45M
-12.72%13.97M
22.56%21.22M
6.85%-3.36M
58.82%-4.76M
256.03%16.00M
184.87%17.31M
90.14%-3.60M
91.46%-11.55M
-10811.70%-10.26M
Net financing
----
-80.85%9.00K
--0.00
-83.53%14.00K
----
2.17%47.00K
--0.00
-4.49%85.00K
--8.74M
107.82%46.00K
100.00%0.00
121.92%89.00K
-100.00%0.00
-229.23%-588.00K
-1027.27%-408.00K
-177.63%-406.00K
-99.97%49.00K
13.18%455.00K
0.00%44.00K
132.77%523.00K

FAQs

What are the current assets of Passage Bio Inc?

According to Passage Bio Inc's FY2025 earnings report, its current assets were 47.76M, with a year-on-year change of -39.40.

What are the total assets of Passage Bio Inc?

According to Passage Bio Inc's FY2025 earnings report, its total assets of Passage Bio Inc were 62.28M, with a year-on-year change of -39.19.

What are the total liabilities of Passage Bio Inc?

According to Passage Bio Inc's FY2025 earnings report, its total liabilities of Passage Bio Inc were 43.53M, with a year-on-year change of 5.77.

What is the total equity of Passage Bio Inc?

According to Passage Bio Inc's FY2025 earnings report, its total equity of Passage Bio Inc was 18.75M, with a year-on-year change of -69.39.

What is the net operating income of Passage Bio Inc?

According to Passage Bio Inc's FY2025 earnings report, its net operating income of Passage Bio Inc was -43.15M, with a year-on-year change of 33.78.

What is the net investment of Passage Bio Inc?

According to Passage Bio Inc's FY2025 earnings report, its net investment of Passage Bio Inc was 40.22M, with a year-on-year change of -26.81.

What is the net financing of Passage Bio Inc?

According to Passage Bio Inc's FY2025 earnings report, its net financing of Passage Bio Inc was 23.00K, with a year-on-year change of -99.74.

What is the Earnings Per Share (EPS) of Passage Bio Inc?

According to Passage Bio Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -14.35, with a year-on-year change of 33.09.

What is the net income of Passage Bio Inc?

According to Passage Bio Inc's FY2025 earnings report, its net income was -45.52M, with a year-on-year change of 29.71.

What is the Return on Equity (ROE) of Passage Bio Inc?

According to Passage Bio Inc's FY2025 earnings report, its Return on Equity (ROE) was -113.78, with a year-on-year change of -51.56.

What is the Return on Assets (ROA) of Passage Bio Inc?

According to Passage Bio Inc's FY2025 earnings report, its Return on Assets (ROA) was -55.28, with a year-on-year change of -7.95.

What is the operating profit of Passage Bio Inc?

According to Passage Bio Inc's FY2025 earnings report, its operating profit was -43.15M, with a year-on-year change of 33.78.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.